(Q45800171)

16 December 2017

title

Metastasis awakening: the challenges of targeting minimal residual cancer (English)

1 reference

16 December 2017

author name string

Bernhard Polzer

series ordinal

1

1 reference

16 December 2017

Christoph A Klein

series ordinal

2

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

16 December 2017

published in

Nature Medicine

1 reference

16 December 2017

volume

19

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

274-275

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.1038/nm.3121

exact match

0 references

cites work

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

21 January 2018

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

21 January 2018

1 reference

Cerebral hemorrhage, warfarin, and intravenous tPA: the real risk is not treating.

21 January 2018

1 reference

Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study

21 January 2018

1 reference

EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma

21 January 2018

1 reference

Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence

21 January 2018

1 reference

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

21 January 2018

1 reference

Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer

21 January 2018

1 reference

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

21 January 2018

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

The life history of 21 breast cancers

21 January 2018

1 reference

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23467237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Resistance to BRAF-targeted therapy in melanoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM.3121

1 reference

16 December 2017

Dimensions Publication ID

1011508018

0 references

1 reference

16 December 2017